Fundz

Gero secures $17M in new financing, totaling $34M in equity funding, to develop medicines that slow aging. The funding will support their physics-first AI approach and collaboration with Chugai Pharmaceutical.

PRIVATEJun 17, 2026

Amount Raised

$17 Million

Round Type

Venture

San FranciscoBiotechnologyHealth CareArtificial Intelligence

Description

Gero has announced $17M in new financing, bringing total equity funding to $34M. The company leverages a physics-first AI approach and longitudinal human data to develop drugs targeting aging and age-related diseases. This funding follows their collaboration with Chugai Pharmaceutical, which includes significant milestone payments. Gero aims to transform our understanding of aging through innovative therapeutic solutions.

Quick answer

Gero raised $17 Million in a funding round, dated June 17, 2026. Gero is based in San Francisco, California, United States.

How much did Gero raise?
Gero raised $17 Million in a funding round on June 17, 2026.
What does Gero do?
Gero is a biotechnology company that leverages physics-first AI and human longitudinal data to develop medicines aimed at slowing aging and treating age-related diseases.
Where is Gero based and how big is it?
Gero is based in San Francisco, California, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Gero that raised within 45 days of this round, from Fundz verified event records.

  • SoundHealth raised $12M (Series A) on July 30, 2026.
  • Sail Biomedicines raised $465M on July 30, 2026.
  • Mirae raised $5.4M on July 28, 2026.
  • Safe Superintelligence raised $3B (Convertible Note) on July 27, 2026.
  • TidalSense raised $19M on July 24, 2026.
  • InnoDtech raised $3.4M (Seed) on July 23, 2026.

Who to call at Gero, and when

A new round usually means Gero is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Gero raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gero, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gero. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Gero

Location

San Francisco, California, United States

About

Gero is a biotechnology company that leverages physics-first AI and human longitudinal data to develop medicines aimed at slowing aging and treating age-related diseases. Their innovative approach combines extensive human medical records with a physics-based framework to identify therapeutic targets and design drugs. By focusing on the quantifiable physical laws of aging, Gero seeks to uncover new treatments that can enhance healthspan and lifespan. The company collaborates with prominent pharmaceutical firms to advance its research and development efforts.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Gero raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Gero's next move

See what Strategic adds

Gero raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.